Earth, and the other planets and stars in our universe, act like huge magnets. The Earth's magnetic field originates in its core, where very hot electrically conducting fluids are flowing. The motion of these molten fluids generates a flowing current like current in an electrical wire.  Current flowing through a coil generates a magnetic field.  The strength of a magnetic field is measured in Tesla (T).  Earth's magnetic field is 0.00005 Tesla. Although this is an extremely weak field, it produces an effect on a compass. (Czernia, 2022)  

​

Everyone on earth spends their whole life, from the moment of conception to their last breath, in a magnetic field of 0.00005 Tesla. The Halo device produces the same exact strength of electromagnetic field as Earth, at 0.00005 Tesla. It only has an effect because the field pulses (turns on and off).

 

Earth's magnetic field is constant.  It doesn't oscillate.  In other words, it doesn't have a frequency. Humans aren't designed to keep track of anything that is constant. If we're in a place with central heat or air conditioning, we only tend to notice it when it turns on or off.  If we go into a stinky locker room, after a while the smell seems to disappear.  

 

Your brain cells do have frequencies (pulsating signals) that correspond with different areas of the brain.  How well those areas are functioning depends on how well they are performing at the appropriate frequency at which they're designed to function. When areas of the brain are sending signals at a rate that's too fast or too slow, then the brain loses efficiency.

​

The Halo's field is set to pulse at a frequency determined by a brain map.  Pulsation guides the brain to behave at a specified frequency in order to regain or establish optimal function. Pulsation helps the brain take notice of the field so the brain can follow the timing of the pulses.   The Halo's weak field provided at a specific frequency allows cells to respond to its gentle influence. 

​

Halo neurotherapy is a painless treatment -- also called subthreshold (too weak to hurt). It requires no paste or preparation.  

 

The first experiments with PEMF were done at NASA to help astronauts in low-gravity conditions.  It earned FDA approval in the early 1980s to help with repair of "nonunion" bone fractures.  In 2015, the FDA reclassified PEMF devices from Class 3 to Class 2 status (a step up).  In 2017, the first over-the-counter device was approved by the FDA. 

 

Treatment with PEMF is known for pain relief (analgesia) and for treatment of inflammatory conditions. PEMF devices have been studied for knee osteoarthritis, depression, postoperative pain, and musculoskeletal pain.  PEMFs exhibit strong neuroprotective effects in the nervous system. In ischemic stroke, weak PEMFs can promote functional recovery by activation of the brain derived neurotrophic factor/tropomyosin receptor kinase B/protein kinase B signaling pathway (Wang et al., 2019). Additionally, PEMF can modulate the expression of microRNAs and stimulate tissue regeneration in in vitro models of Alzheimer's disease (Capelli et al., 2017).  And weak PEMF exposure has a neuroprotective effect in vivo after ischemic stroke in mice  (Urnukhsaikhan et al., 2017).

​

If you are interested and have questions about how this technology might help, a consultation is free and welcomed.  Dr. Fisher is best reached by text at 310.03.7449, or by the contact form in the footer of this site.